Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 2011 Apr;32(4):197-200. doi: 10.1016/j.tips.2011.02.006. Epub 2011 Mar 31.

Paradoxical pharmacology: turning our pharmacological models upside down.

Author information

1
Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, Franklin Wilkins Building, Waterloo Campus, King's College London, 150 Stamford Street, London SE1 9NH, UK. clive.page@kcl.ac.uk

Abstract

Paradoxical pharmacology is a term first suggested by Richard Bond to refer to intriguing observations that chronic use of some drug types can have the opposite biological effect(s) to those seen following acute administration of the same drug. A good example of 'paradoxical pharmacology' is the research Richard has pioneered showing that whereas acute administration of β-blockers is contraindicated in the treatment of asthma, chronic use of certain β-blockers can have therapeutic benefit. It would appear that those β-blockers that can act as inverse agonists at the β2 receptor particularly show this paradoxical effect and the findings of Richard's research not only challenge the dogma of the treatment of asthma but also challenge many of the pharmacological principles of ligand/receptor interactions established by Sir James Black and others. In this paper, I discuss Richard's efforts to evaluate the chronic effects of β-blockers in the airways and how this research caught the imagination of Sir James Black.

PMID:
21458081
DOI:
10.1016/j.tips.2011.02.006
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center